MalariaCare is a five-year partnership led by PATH and funded by the US Agency for International Development (USAID) under the US President’s Malaria Initiative (PMI). MalariaCare aims to scale up high-quality diagnosis and treatment services for malaria and other febrile illnesses.
We work in PMI focus countries and other countries in Africa and the Mekong Region to reduce the burden of serious disease and promote healthy communities and families.
- Improve the accuracy of diagnostic testing in the health sector.
- Increase the percentage of suspected malaria patients who receive a diagnostic test for malaria.
- Increase the percentage of patients who receive appropriate treatment for malaria or other febrile illness, consistent with test results.
- Strengthen health systems at country level for the diagnosis and treatment of malaria and other infectious diseases, with a focus on laboratory support.
The MalariaCare partners include PATH, Medical Care Development International (MCDI), Population Services International (PSI), and Save the Children US (SC US). Each partner has extensive experience in designing and implementing malaria control programs in high-burden countries. The MalariaCare team’s expertise includes laboratory strengthening, malaria diagnosis and treatment, program evaluation and research, and community-based management of disease in both the public and private sectors.
Photo: PATH/Laura Newman